Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. Log out ...

nephritis, and nephrotic syndrome. Late manifestations result primarily from chronic inflammation of bone, teeth, and CNS. [6] Infants who are symptomatic are evaluated and treated. Asymptomatic ...

Supported by a grant from the Commonwealth Fund of New York, Grants No. H-1529 of the National Heart Institute and A-808 of the National Institute of Arthritis and Metabolic Diseases, United ...

Cancers have been the top cause of death for the past 42 years, the ministry said. Last year, cancer killed 53,126 people, ...

In addition to REGENCY, Gazyva is being investigated in children and adolescents with lupus nephritis, people with membranous nephropathy, childhood-onset idiopathic nephrotic syndrome and ...

Positive topline results were announced from a phase 3 study of obinutuzumab in patients with lupus nephritis.

Roche further stated that it is also currently evaluating Gazyva/Gazyvaro in separate late-stage studies to treat children and adolescents with lupus nephritis, people with membranous nephropathy ...

Gazyva is also being studied in children and adolescents with lupus nephritis and patients with membranous nephropathy, childhood-onset idiopathic nephrotic syndrome and SLE. The SLE market is ...

In addition to REGENCY, Gazyva/Gazyvaro is being investigated in children and adolescents with lupus nephritis, people with membranous nephropathy, childhood-onset idiopathic nephrotic syndrome and ...

Belimumab and voclosporin have unique mechanisms of action, impacting their efficacy and safety profiles in lupus nephritis treatment. Payers consider clinical outcomes, cost, and value when ...